Will NgAgo strongly challenge CRISPR in coming years? Take our poll and also see the results to find out what others thought. 2020 update: NgoAgo has ending up going nowhere, but 4 years ago we didn’t know that would be it’s fate although some of us were skeptical early on.
Poll: Will NgAgo strongly challenge CRISPR in coming years? Read More »
Poll on the REGROW Act. What do you think of this healthcare legislation?
Poll for ISSCR 2016 attendees: what’s your view of REGROW Act? Read More »
Note that this poll is focused on germline, heritable genetic modification. Thus, it does not include somatic cell/gene therapy applications.
Poll #GeneEditSummit: a moratorium on human genetic modification? Read More »
A few weeks back I started a poll focusing on whether people would have a designer baby if they could. With nearly 200 responses so far, the results are very mixed (see image). One conclusion from this I think is that we need more information on possible risks versus benefits. Another element here is that
Poll finds near equal split on question: would you have a designer baby? Read More »
Please take our new poll. Would you have a genetically modified baby? There are a lot of issues and even feelings to factor into this question Please tell us in the comments why you voted the way you did.
Poll: Would you have a genetically modified baby? Read More »
Is sex a form of genetic modification? A fairly common argument out there is that human decisions about mates and then their actual sexual reproduction are forms of human genetic modification. Sex is also sometimes equated with genetic modification of organisms by a few scientists. What do you think? Are these things equivalent? Similar? Not
Poll: Is sex a form of human genetic modification? Read More »
I recently ran a poll on my blog about how the FDA is doing on handling stem cell clinics. There is substantial debate in the stem cell arena about how the FDA handles stem cell clinics ranging from the view that the agency is far too strict to excessively lenient. The results of the poll
FDA far too weak on stem cell clinics says poll Read More »
In a poll on CRISPR, respondents so far have predominantly viewed potential off-target effects as a moderate (28%) to substantial (25%) problem. The poll is still running if you are interested in participating. As to the more polar answers, only 20% and 4% answered “minor” or “a non-issue”, respectively, while 14% thought that off-target effects
CRISPR off-target effects important, but not severe challenge, says poll Read More »
